Boston Children's Hospital
Jan M. Bell spends much of his time researching Microbiology, Antibacterial agent, Antibiotics, Klebsiella pneumoniae and Drug resistance. Jan M. Bell studied Microbiology and Staphylococcus aureus that intersect with Antibiotic resistance. Jan M. Bell has researched Antibacterial agent in several fields, including Enterococcus faecalis and Genotype.
His studies examine the connections between Klebsiella pneumoniae and genetics, as well as such issues in Aztreonam, with regards to Outbreak and Virology. Vancomycin is closely connected to Multiple drug resistance in his research, which is encompassed under the umbrella topic of Antimicrobial. His studies in Broth microdilution integrate themes in fields like Acinetobacter baumannii and Carbapenem.
Jan M. Bell mainly focuses on Microbiology, Antibacterial agent, Antimicrobial, Antibiotic resistance and Drug resistance. His Microbiology study combines topics in areas such as Vancomycin, Staphylococcus aureus and Klebsiella pneumoniae. His Antibacterial agent research integrates issues from Cefepime and Etest.
His work carried out in the field of Antimicrobial brings together such families of science as Clindamycin, Traditional medicine, Moraxella catarrhalis and Doripenem. His research in Antibiotic resistance intersects with topics in Ciprofloxacin, Erythromycin, Veterinary medicine, Trimethoprim and Ceftriaxone. Jan M. Bell works mostly in the field of Drug resistance, limiting it down to concerns involving Pulsed-field gel electrophoresis and, occasionally, Ribotyping.
His main research concerns Microbiology, Antibiotic resistance, Cephalosporin, Ceftriaxone and Drug resistance. The study incorporates disciplines such as Staphylococcal infections, Staphylococcus aureus and Enterobacter cloacae in addition to Microbiology. Jan M. Bell usually deals with Staphylococcus aureus and limits it to topics linked to Antibacterial activity and Antibiotics.
His work deals with themes such as Vancomycin, Antimicrobial, Gentamicin and Fusidic acid, which intersect with Antibiotic resistance. His Ceftriaxone research is multidisciplinary, incorporating perspectives in Ciprofloxacin and Escherichia coli. His Drug resistance study frequently draws connections between adjacent fields such as Veterinary medicine.
The scientist’s investigation covers issues in Microbiology, Staphylococcus aureus, Polymerase chain reaction, Disc diameter and Penicillin. His work in the fields of Microbiology, such as Cefepime, intersects with other areas such as Context. The various areas that Jan M. Bell examines in his Staphylococcus aureus study include DNA ligase, Enzyme inhibitor, Enzyme, Mode of action and Biotin.
His Polymerase chain reaction study combines topics from a wide range of disciplines, such as Genotyping, Locus, Multilocus sequence typing and DNA sequencing. Jan M. Bell integrates many fields, such as Disc diameter and engineering, in his works.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999
D. J. Diekema;M. A. Pfaller;F. J. Schmitz;J. Smayevsky.
Clinical Infectious Diseases (2001)
Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community
Keiko Okuma;Kozue Iwakawa;John D. Turnidge;Warren B. Grubb.
Journal of Clinical Microbiology (2002)
Early Dissemination of NDM-1- and OXA-181-Producing Enterobacteriaceae in Indian Hospitals: Report from the SENTRY Antimicrobial Surveillance Program, 2006-2007
Mariana Castanheira;Lalitagauri M. Deshpande;Dilip Mathai;Jan M. Bell.
Antimicrobial Agents and Chemotherapy (2011)
Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Benjamin P Howden;Christopher R E McEvoy;David L Allen;Kyra Y L Chua;Kyra Y L Chua.
PLOS Pathogens (2011)
Emergence of Vancomycin-Resistant Enterococci in Australia: Phenotypic and Genotypic Characteristics of Isolates
Jan M. Bell;James C. Paton;John Turnidge.
Journal of Clinical Microbiology (1998)
Dissemination of the Metallo-β-Lactamase Gene blaIMP-4 among Gram-Negative Pathogens in a Clinical Setting in Australia
Anton Y. Peleg;Clare Franklin;Jan M. Bell;Denis W. Spelman.
Clinical Infectious Diseases (2005)
Genetic Characterization of vanG, a Novel Vancomycin Resistance Locus of Enterococcus faecalis
Stuart J. McKessar;Anne M. Berry;Jan M. Bell;John D. Turnidge.
Antimicrobial Agents and Chemotherapy (2000)
Regional variation in the prevalence of extended-spectrum beta-lactamase-producing clinical isolates in the Asia-Pacific region (SENTRY 1998-2002).
Yoichi Hirakata;Junichi Matsuda;Yoshitsugu Miyazaki;Shimeru Kamihira.
Diagnostic Microbiology and Infectious Disease (2005)
Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program.
Rodrigo E Mendes;Jan M Bell;John D Turnidge;John D Turnidge;Mariana Castanheira.
Journal of Antimicrobial Chemotherapy (2008)
In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae
Anima Poudyal;Benjamin P. Howden;Jan M. Bell;Jan M. Bell;Wei Gao.
Journal of Antimicrobial Chemotherapy (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: